Latest filing published 23 Sept 2026 for AKTIS ONCOLOGY INC, €483k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Akos Czibere appears in our data through filings on Aktis Oncology, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 8 July 2026 to 23 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 23 September 2026 with a transaction (€483k) in Aktis Oncology, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations